Form 4: HealthEquity Director Acquires Shares

HealthEquity Director Gayle Furgurson Wellborn acquired 2,877 shares of common stock.

Summary

• Gayle Furgurson Wellborn, a Director at HealthEquity, Inc., acquired 2,877 shares of common stock on June 25, 2026.
• The acquisition was made at a price of $0, indicating these were likely granted shares or units.
• Following this transaction, Ms. Wellborn beneficially owns 22,610 shares of common stock.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event, as director share acquisitions can indicate confidence, but the transaction itself is a standard equity award fulfillment.

Positives

• Director acquisition of shares can signal confidence in the company's future prospects.
• The acquisition of 2,877 shares at no cost suggests an equity award or grant.

Future Outlook

The filing indicates that restricted stock units will vest in full on the earlier of June 25, 2027, or the date of the issuer's next annual stockholder meeting in June 2027. Vested shares will be delivered upon vesting.

Industry Context

StockSavvy.ai notes that insider transactions, such as this share acquisition by a director, are common in the health technology and financial services sectors, particularly for companies like HealthEquity that manage health savings accounts and related benefits.

Stakeholder Impact

• Shareholders: The acquisition by a director may be viewed positively, suggesting insider confidence, but does not immediately impact share count or market dynamics.
• Management: The transaction reflects the fulfillment of equity compensation plans.

Next Steps

• Vesting of restricted stock units on or before June 25, 2027.
• Delivery of vested shares to the reporting person upon vesting.

Key Dates

Keywords

HealthEquity, HQY, Form 4, Insider Trading, Director, Common Stock, Share Acquisition